Adding ezetimibe to simvastatin: Results of the IMPROVE-IT trial
Jan 07, 2015•7 min•Ep. 47
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Alistair Lindsey talks to Christopher Cannon, Havard Clinical Research Institute, about the results of his IMPROVE-IT trial, which examined clinical outcomes of adding ezetimibe to simvastatin.
This podcast was recorded at the American Heart Association scientific sessions in Chicago.
For the best experience, listen in Metacast app for iOS or Android